An open-label phase 1/2a trial of a genetically modified rodent malaria parasite for immunization against <i>Plasmodium falciparum</i> malaria
Isaie J. Reuling, António M. Mendes, Gerdie M. de Jong, Amanda Fabra-García, Helena Nunes‐Cabaço, Geert‐Jan van Gemert, Wouter Graumans, Luc E. Coffeng, Sake J. de Vlas, Annie Yang, Cynthia Lee, Yimin Wu, Ashley J. Birkett, Christian F. Ockenhouse, Rob Koelewijn, Jaap J. van Hellemond, Perry J. J. van Genderen, Robert W. Sauerwein, Miguel Prudêncio
Abstract
Clinical evaluation of genetically modified rodent malaria parasites for whole-sporozoite immunization against P. falciparum in healthy volunteers.
Topics & Concepts
MalariaPlasmodium falciparumRodentVirologyParasite hostingImmunizationBiologyGenetically modified organismPlasmodium (life cycle)Rodent modelMalaria vaccineImmunologyMedicineGeneticsAntigenGeneWorld Wide WebEcologyEndocrinologyComputer scienceMalaria Research and ControlMosquito-borne diseases and controlViral Infections and Vectors